Alexandros D. Tselepis
Researcher Next ID · RN-026943
Researcher · Medicine
Ioannina, Greece
- Works count
- 347
- Citation count
- 18,904
- H-index
- 52
- i10-index
- 198
Research interests
Publications
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
European Heart Journal · 2019 · https://doi.org/10.1093/eurheartj/ehz455
The pathway of neutrophil extracellular traps towards atherosclerosis and thrombosis
Atherosclerosis · 2019 · https://doi.org/10.1016/j.atherosclerosis.2019.06.919
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
Metabolism · 2017 · https://doi.org/10.1016/j.metabol.2017.02.014
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Current Vascular Pharmacology · 2011 · https://doi.org/10.2174/157016111796642661
Τhe role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2009 · https://doi.org/10.1016/j.bbalip.2009.02.015
New Insights Into the Role of Lipoprotein(a)-Associated Lipoprotein-Associated Phospholipase A 2 in Atherosclerosis and Cardiovascular Disease
Arteriosclerosis Thrombosis and Vascular Biology · 2007 · https://doi.org/10.1161/01.atv.0000280571.28102.d4
Oxidative Stress Is Progressively Enhanced With Advancing Stages of CKD
American Journal of Kidney Diseases · 2006 · https://doi.org/10.1053/j.ajkd.2006.08.015
Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment – a prospective, controlled study
Arthritis Research & Therapy · 2006 · https://doi.org/10.1186/ar1952
Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Small, Dense LDL Particles in Human Plasma
Clinical Chemistry · 2005 · https://doi.org/10.1373/clinchem.2005.058404
Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase
Atherosclerosis Supplements · 2002 · https://doi.org/10.1016/s1567-5688(02)00045-4
Atorvastatin Preferentially Reduces LDL-Associated Platelet-Activating Factor Acetylhydrolase Activity in Dyslipidemias of Type IIA and Type IIB
Arteriosclerosis Thrombosis and Vascular Biology · 2002 · https://doi.org/10.1161/hq0202.102918
Laparoscopic surgery-induced changes in oxidative stress markers in human plasma
Surgical Endoscopy · 2001 · https://doi.org/10.1007/s00464-001-0034-2
PAF-Degrading Acetylhydrolase Is Preferentially Associated With Dense LDL and VHDL-1 in Human Plasma
Arteriosclerosis Thrombosis and Vascular Biology · 1995 · https://doi.org/10.1161/01.atv.15.10.1764
Current projects
No projects listed.